MedPath

Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients

Not Applicable
Recruiting
Conditions
Depression
Medication Adherence
Registration Number
NCT06109610
Lead Sponsor
Mattu University
Brief Summary

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Cognitive behavioral therapy may solve these problem.

Detailed Description

Depression is highly comorbid with HIV/ AIDS and is associated with worse poor adherence to antiretroviral therapy (ART), and potentially to long-term immune functioning. Poor adherence decreases the benefits of ART as well as chances of prolonged survival. An intervention that integrates CBT for depression with a cognitive behavioral approach to adherence counseling (cognitive behavioral therapy intervention for adherence and depression (CBT-AD)) has been found to be effective in improving adherence and reducing depression in PLWH.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  • PLWHA who were 18 years old and above were included in the study
Exclusion Criteria
  • PLWHA who were previously took CBT and participants with acute physical or mental disturbances were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The mean score of Depression will change after interventionThrough study completion, an average of 1 yea

Depression is measured by Patient Health Questionnaire (PHQ-9) Depression Scale. The minimum value is 0 and the maximum value is 27. The higher score mean worse outcome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mattu University

🇪🇹

Addis Ababa, Ethiopia

Mattu University
🇪🇹Addis Ababa, Ethiopia
Yadeta Alemayehu, MSc
Contact
0984569410
yadoalex45@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.